Medical Devices & Translation Requirements for the Greek Market: Lessons from Team-NB v4

Scope of MDR Technical Documentation Guidance

The Team-NB Position Paper acts as a harmonized manual for Notified Bodies to evaluate technical files under Regulation (EU) 2017/745. It provides a granular framework for documenting device design, manufacturing, and clinical evidence to ensure submissions are “clear, organized, readily searchable, and unambiguous”. A pivotal aspect of this framework is the Translation Strategy, which mandates that all information accompanying a device must be as clinically and technically rigorous in its translated form as it is in the master file.

Core Translation and Language Requirements

The following sections of the technical documentation are explicitly subject to language and translation mandates:

Communication & Application

Manufacturers must contact their Notified Body (NB) prior to application to clarify specific language requirements for the technical documentation submission, as per MDR Article 52(12).

Market Evidence

The technical file must include a specific list of EU countries intended for marketing, along with evidence that national language requirements for each territory have been strictly followed.

Instructions for Use (IFU) & Labeling

IFUs and labels (including sterile, sales, and transport packaging) must be provided in the languages accepted by the Member States where the device is sold. If electronic IFUs (e-IFUs) are used, they must be available on the manufacturer’s website in the official Union language(s) determined by the relevant Member State.

Supplementary Material

If a device includes a Patient Handbook, Physicians’ Handbook, or an Implant Card, these must be provided in the accepted national languages for any information not expressed via harmonized symbols.

Design & Manufacturing Data

If manufacturing information is not available in English, the manufacturer must provide full translations or supplementary summary reports with translated sections.

Software & Interface

The software requirements analysis must account for “language scalability”. Furthermore, many Member States (e.g., France, Portugal) treat the Graphical User Interface (GUI) similarly to labeling, requiring it to be in the national language if it impacts safety.

SSCP (Summary of Safety and Clinical Performance)

This must be translated into the languages of all Member States where the device is sold. The wording for the “layperson” section must be specifically adapted to non-medical reading levels.

Preventable Frictions and Compliance Failures in the Greek Market

Analysis of the Team-NB Position Paper (v4) and the MDR – Language requirements for manufacturers (Rev. 3) reveals specific “regulatory frictions” that can stall market entry in Greece. These avoidable delays often stem from a misunderstanding of how national mandates intersect with the technical file.

The Greek Language Mandate vs. English Exceptions

While some Member States allow English for professional use, Greece maintains a strict stance on the Greek language for information accompanying the device.

The Problem: Manufacturers often assume that because a device is for professional use, English documentation will suffice.
The Reality: Greek law (Decrees ΔΥ8δ/Γ.Π.οικ. 130644 & 130648) mandates Greek for labeling and instructions for use.
Preventable Failure: Exceptionally, English may be accepted for professional users in Greece, but only after explicit approval from the Competent Authority (EOF). Proceeding without this formal approval is a direct route to noncompliance.

Inconsistent Language within the Technical Documentation

The document Inconsistent language within the Technical Documentation.docx identifies a major pitfall: presenting key information in multiple locations with conflicting details.

The Risk: If the “Intended Purpose” or “Side Effects” in your Greek instructions for use do not perfectly align with the English clinical evaluation or risk management sections, the Notified Body may issue a negative recommendation for certification.
The Friction: Poor quality translations lead to additional questions from auditors and significant time lost during assessment.

The “Layperson” Communication Gap in the SSCP

The Summary of Safety and Clinical Performance (SSCP) is a frequent site of audit failure.

Terminology Issues: Manufacturers often write the SSCP using regulatory or quality systems language that is not understood by patients.
Greek Market Specifics: For the Greek market, the layperson section must be specifically adapted to the reading skills of someone without formal medical education.
Preventable Failure: Failing to confirm the language preference for SSCP validation with your Notified Body early on can lead to costly rework of the Greek clinical summaries.

Omission of Supplementary Handbooks

The Team-NB guidance emphasizes that if a device is accompanied by a Patient Handbook, Physicians’ Handbook, or Implant Card, these are not optional for translation.

The Trap: Manufacturers sometimes translate the primary IFU but leave supplemental guides in English.
The Requirement: All information not expressed in harmonized symbols must be provided in Greek if the device is sold in Greece. Missing these secondary documents creates a “gap” in the technical file that auditors will immediately flag.

Ensure Your Documentation Is Audit-Ready

The Team-NB guidance is clear: poor translations lead to additional questions and stalled assessments. Do not let a linguistic technicality become a regulatory barrier.

For professional alignment of your technical documentation with these Greek-specific mandates, you can explore my specialized services to ensure your submissions meet both EOF and MDR requirements.